Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

06 Mar 2018 Evaluate

Glenmark Pharmaceuticals has informed about press release titled ‘Glenmark Pharmaceuticals Presents New Data on Ryaltris, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis at the AAAAI/WAO Joint Congress’.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..